ERBB2 and bladder transitional cell carcinoma: However, it appears to be a hallmark of urothelial carcinoma of the urinary bladder that typical progression markers such as p53 alterations [19], HER2 overexpression [20], and MYC alterations [21] are not prognostic in these tumors.